Do gastric inhibitory polypeptide and glucagon-like peptide-1 (7-36) amide contribute to the hyperinsulinaemia of pregnancy?
Gama
R
R
Department of Clinical Biochemistry, Royal Surrey County, Guildford, United Kingdom.
Watkins
K
K
Morgan
L
L
Wright
J
J
Hampton
S
S
Marks
V
V
D000328:Adult; D001786:Blood Glucose / Q000502:physiology; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000097:blood*; D005934:Glucagon / Q000097:blood*; D052216:Glucagon-Like Peptide 1; D005951:Glucose Tolerance Test; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood*; D007328:Insulin / Q000097:blood / Q000276:immunology; D010446:Peptide Fragments / Q000097:blood*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood*; D017697:Premenopause / Q000097:blood; D011498:Protein Precursors / Q000097:blood*
D001786:Blood Glucose; D007328:Insulin; D010446:Peptide Fragments; D011498:Protein Precursors; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1; D005934:Glucagon